TY - JOUR
T1 - What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine
AU - Bolotin, Shelly
AU - Harvill, Eric T.
AU - Crowcroft, Natasha S.
N1 - Publisher Copyright:
© Published by Oxford University Press on behalf of FEMS 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Pertussis (whooping cough) is a respiratory disease caused by the bacterium Bordetella pertussis. Despite the implementation of immunization programs and high vaccine coverage in most jurisdictions, pertussis is still one of the most common vaccine-preventable diseases, suggesting that the current vaccines and immunization schedules have not been sufficiently effective. Several factors are thought to contribute to this. The acellular pertussis vaccine that has been used in many jurisdictions since the 1990s is less effective than the previously used whole-cell vaccine, with immunity waning over time. Both whole-cell and acellular pertussis vaccines are effective at reducing disease severity but not transmission, resulting in outbreaks in vaccinated cohorts. In this review, we discuss various limitations of the current approaches to protection from pertussis and outline various options for reducing the burden of pertussis on a population level.
AB - Pertussis (whooping cough) is a respiratory disease caused by the bacterium Bordetella pertussis. Despite the implementation of immunization programs and high vaccine coverage in most jurisdictions, pertussis is still one of the most common vaccine-preventable diseases, suggesting that the current vaccines and immunization schedules have not been sufficiently effective. Several factors are thought to contribute to this. The acellular pertussis vaccine that has been used in many jurisdictions since the 1990s is less effective than the previously used whole-cell vaccine, with immunity waning over time. Both whole-cell and acellular pertussis vaccines are effective at reducing disease severity but not transmission, resulting in outbreaks in vaccinated cohorts. In this review, we discuss various limitations of the current approaches to protection from pertussis and outline various options for reducing the burden of pertussis on a population level.
UR - http://www.scopus.com/inward/record.url?scp=84966679312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84966679312&partnerID=8YFLogxK
U2 - 10.1093/femspd/ftv057
DO - 10.1093/femspd/ftv057
M3 - Review article
C2 - 26253079
AN - SCOPUS:84966679312
SN - 2049-632X
VL - 73
SP - ftv057
JO - Pathogens and disease
JF - Pathogens and disease
IS - 8
ER -